Any therapeutic use occurs under physician supervision as off-label research application requiring comprehensive informed consent, medical monitoring, and understanding that the peptide is not an approved pharmaceutical agent
In diet-induced obesity (DIO) models, NNMT loss-of-function and selective small-molecule inhibitors reduce white adipose mass and improve metabolic parameters without overt toxicity, positioning NNMT as a tractable target for metabolic-disease research [24]
[DOI] [PMC free article] [PubMed] [Google Scholar] 12.Rompolas P., Deschene E.R., Zito G., Gonzalez D.G., Saotome I., Haberman A.M., Greco V
+ B12 injections suit vegetarians and vegans who do not eat animal foods, patients with confirmed absorption issues such as pernicious anaemia, coeliac disease or significant IBS, older adults whose stomach acid has dropped with age, and patients on long-term metformin or proton-pump inhibitors that lower B12 absorption